Hydroxychloroquine-Remdesivir Combo Dangerous for COVID-19 Patients: FDA

TUESDAY, June 16, 2020 -- The drugs promoted by President Donald Trump as treatments for COVID-19 should not be used with the experimental drug remdesivir because of a potentially unfavorable drug interaction, the U.S. Food and Drug Administration...
Source: Drugs.com - Daily MedNews - Category: General Medicine Source Type: news